Tracked deals
6295
6295 tracked deals across 2007-2026.
Tracked deals
6295
6295 tracked deals across 2007-2026.
Buyer mix
Mixed buyer set
4968 strategic · 3290 pe
Top trend
Volume peaked in 2022
1005 tracked deals announced in 2022.
Primary Insight
Build a buyer list for your Healthcare Services deal
Find buyers actively acquiring healthcare services companies.
Find buyers like these for your dealBuyer Snapshot
Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.
| Buyer | # Deals | Focus | Type |
|---|---|---|---|
| NMS Capital | 65 | Private equity firm focused on lower middle market invest... | PE |
| The Riverside Company | 29 | Global private equity firm focused on the smaller end of ... | PE |
| Gryphon Investors | 28 | Middle-market private equity firm and sponsor; provides c... | PE |
| Revelstoke Capital Partners | 26 | Healthcare-focused private equity firm that partners with... | PE |
| Sheridan Capital Partners | 24 | Chicago-based healthcare private equity firm focused on l... | PE |
| H.I.G. Capital | 22 | Global alternative investment firm providing equity and d... | PE |
| HCAP Partners | 22 | Southern California-based private equity and mezzanine de... | PE |
| Linden Capital Partners | 22 | Healthcare-focused private equity firm investing in middl... | PE |
| BayMark Health Services | 21 | Operator of medication-assisted treatment (MAT) and behav... | Strategic (PE-backed) |
| Great Point Partners | 21 | Healthcare-focused private equity firm investing in healt... | PE |
Last 10 years
Supporting Data
Integrity Care Group acquired 15 NextCare clinics—nine in Oklahoma, four in Missouri and two in Nebraska—with approximately 200 employees joining Integrity. The acquisition expands Integrity’s Oklahoma presence and marks its entry into Missouri and Nebraska, growing its network to 100 locations across five states.
CD&R and McKesson entered into a definitive agreement to acquire Option Care Health for $32.05 per share, valuing the company at approximately $5.8 billion. CD&R will hold an approximately 51% stake and McKesson an approximately 49% stake; the transaction is expected to close in the first half of 2027, subject to shareholder and regulatory approvals.
Harbor Health has agreed to acquire 27 Village Medical clinics across the Greater Houston area, expanding Harbor’s combined healthcare delivery and insurance footprint in Texas. The transaction is expected to close by the end of 2026, with the acquired clinics continuing to operate under the Village Medical brand and joining the Harbor Health Insurance provider network.
Viome acquired Sōlaria Biō, a clinically validated synbiotics and medical foods company, to expand its personalized health platform into condition-specific interventions. The deal brings Sōlaria’s microbial discovery platform, biobank, machine-learning capabilities, and products—most notably its standalone synbiotic medical food Bōndia—into Viome’s portfolio.
Healthcare Services Group acquired NEXDINE Hospitality for $93.5 million upfront, with potential additional contingent consideration tied to performance targets. NEXDINE will operate as a wholly owned subsidiary, retaining its brand, Mansfield headquarters, and existing leadership team; the acquisition expands Healthcare Services Group’s capabilities and presence in senior living and hospitality-oriented care markets.
Astera Healthcare, an independent physician-owned multi-specialty practice in New Jersey, welcomed Garden State Urology into its physician-led platform. The combination expands Astera Urology to 25 urologists and increases access to adult and pediatric urologic care across Morris, Union, and Passaic counties.
Clarivate Plc has completed the sale of its Life Sciences & Healthcare segment to Altaris, LLC for $600 million. The divestiture strengthens Clarivate’s balance sheet and helps the company focus on its Academia & Government and Intellectual Property segments.
iRhythm completed its acquisition of VitalConnect to expand its cardiac monitoring platform across ambulatory, inpatient, remote, and hospital-to-home care. Consideration included $237.5 million in cash (subject to adjustments) plus stock issued at closing, and iRhythm provided $10 million in working capital funding between signing and closing.
Grindr has agreed to acquire PurposeMed, the parent company of HIV prevention telehealth provider Freddie, for $250 million in cash and stock, with total consideration potentially rising to $320 million based on performance milestones. The transaction is expected to close in the fourth quarter of 2026, subject to closing conditions, and Freddie will be integrated into Grindr’s Grindr Health experience.
The Marygold Companies, Inc. (MGLD) is involved in a proposed sale to affiliates of Madison Dearborn Partners. The announcement states that Marygold shareholders are expected to receive $2.00 in cash per share, and that the inquiry is focused on whether the deal is fair.
Lifecore Biomedical, Inc. (LFCR) is the subject of an inquiry related to its proposed sale to affiliates of Webster Equity Partners. The announcement states that Lifecore shareholders are expected to receive $6.28 in cash per share plus a contingent value right tied to future revenue and EBITDA milestones through 2030.
SoundThinking, Inc. is set forth as being related to its sale to affiliates of Transom Capital Group. The proposed consideration includes $8.00 per share in cash plus contingent value rights potentially adding up to $3.00 per share.
Nova Capital Management has acquired BMP Group and RB Medical from Andrew Industries. The deal expands Nova’s portfolio across specialized industrial manufacturing and healthcare products, with both companies continuing under existing management structures.
TransPerfect announced it has acquired Synterex, a Dedham, Massachusetts-based clinical and regulatory writing and technology-enabled consulting firm serving biotech and pharmaceutical clients. Synterex’s AgileWriter.ai platform supports AI-assisted authoring and regulatory content workflows, which TransPerfect says will integrate into its Life Sciences offerings as a division.
WaveEdge Capital served as exclusive sell-side M&A advisor to Seraplex in connection with its sale to Prairie Capital. The transaction brings Seraplex into integration with a consortium of Prairie biospecimen companies, aimed at expanding offerings to biopharmaceutical and diagnostic customers.
Hawaii Pacific Health Partners, Inc. acquired All Access Ortho LLC, a Hawaii-based orthopedic urgent care clinic group. WaveEdge Capital served as exclusive sell-side M&A advisor to AAO in connection with the sale, and AAO’s orthopedic surgeons will continue working with the health system.
Resonant Clinical Solutions acquired Germany-based Labfish rental solutions GmbH and its affiliated companies in the U.S. and U.K. Labfish provides end-to-end clinical and laboratory rental equipment, in-house calibration expertise, and importer/exporter of record (IOR/EOR) plus logistics support for clinical trial sites in more than 70 countries.
Intune Physical Therapy (a Highland Ventures company) announced the acquisition of Clear Lake Physical Therapy & Rehab Specialists, a four-clinic outpatient physical therapy practice serving western Wisconsin. The deal marks Intune’s entry into Wisconsin and expands its Midwest footprint to 22 clinics across five states.
TJP, a Renovus Capital Partners portfolio company, acquired Evolution Consulting & Research, a life sciences market research firm, for undisclosed terms. The deal expands TJP’s end-to-end commercialization platform by adding market research capabilities—connecting upfront insights with strategy, creative development, pull-through, and analytics.
Novotech entered into an agreement to acquire Agilex Biolabs, an Adelaide-based Australian specialist bioanalytical laboratory business, from a wholly owned subsidiary of Healius. The deal is intended to expand Novotech’s laboratory capabilities in Australia and strengthen integrated clinical research and laboratory services for biotechnology and pharmaceutical clinical trial sponsors. Financial terms were not disclosed, and closing remains subject to customary regulatory conditions.
GoodVets, a veterinary care platform, announced it has acquired WellHaven Pet Health, a network of over 40 veterinary hospitals across seven states. The deal expands GoodVets’ footprint from 75 to 116 hospitals, adding presence in the Pacific Northwest and Midwest, with WellHaven hospitals transitioning to the GoodVets brand over time.
Copeland completed the acquisition of Dickson, an environmental monitoring and compliance technology provider for highly regulated healthcare and life sciences environments. The companies will combine Dickson’s cloud-native monitoring platform with Copeland’s compression technologies and controls to strengthen end-to-end cold chain visibility, compliance, and risk reduction.
Astoriom acquired the UK operations of life sciences stability storage provider Sampled, specifically Roylance Stability Storage Limited and Roylance Scientific Limited, located in Glasgow. The purchase expands Astoriom’s specialized stability storage and sample management capabilities with added coverage, expertise, and operational resilience for secure, compliant sample storage services.
Independent Pharmacy Cooperative (IPC) acquired IntegralRx, bringing together two organizations that serve independent pharmacies across the United States. IPC plans to preserve IntegralRx’s customer relationships while expanding access to additional purchasing opportunities, products, and pharmacy services; IntegralRx personnel were retained to support a seamless onboarding process.
PAR Excellence Systems acquired Terso Solutions from Promega Corporation to combine two healthcare inventory technology platforms. The combined offering is intended to give hospitals a more integrated platform for tracking medical supplies, tissue, implants, and other high-value products, leveraging Terso’s RFID technology and PAR’s inventory tracking software and roadmap capabilities.
Artisight acquired TMG Global, bringing the healthcare technology services firm’s deployment expertise in-house. The deal is intended to help Artisight scale its AI-powered Smart Hospital platform across U.S. health systems by supporting end-to-end implementation—from site assessment and infrastructure planning through installation, testing, training, and clinical handoff.
NMS Capital launched Asurgence Medical, creating a surgical suite maintenance, repair, and overhaul platform. The platform was formed through the recapitalization of ENDOCORP (with ENDOCORP continuing under its existing brand) and the concurrent acquisition of Medical Optics from Probo Medical, with both operating under Asurgence subsidiaries and existing leadership.
Hyde Park Capital announced that it advised Braille Works on its acquisition by Allyant, a portfolio company of Thompson Street Capital Partners. The transaction combines Braille Works’ alternative format accessibility solutions with Allyant’s platform to deliver broader catalog offerings and continued growth.
Medartis Group acquired the M.A.R.C. Institute in Doral, Florida, creating its first permanent surgical training and bioskills research center outside Europe. The institute will keep its name and continue operating under existing leadership while Medartis plans to invest in modernization and course expansion.
Vizient, a healthcare supply chain and analytics organization, has completed its acquisition of SxanPro, an inventory intelligence company that improves visibility into procedural and high-complexity supply inventory. SxanPro’s patented mobile scanning technology using Unique Device Identification (UDI) helps healthcare organizations understand inventory location, usability, and recall/expiration status, supporting waste reduction and supply chain execution improvements.
Kincell Bio and Cellipont Bioservices completed their merger to create Kincellis Advanced Therapies, a scaled U.S. contract development and manufacturing organization (CDMO) focused on cell therapies and other advanced modalities. The combined platform spans early development through commercial supply across multiple sites in Florida, North Carolina, and Texas, with the equity financing led by NewSpring Capital and debt support from J.P. Morgan.
Everest Clinical Research (“Everest”) announced the acquisition of the Biometrics and Data Services business unit of Firma Clinical Research (“Firma DS”). The deal expands Everest’s global biometrics expertise and clinical data science capabilities, adding an experienced biometrics team and supporting clients across the clinical development lifecycle.
CGF Holdings announced a strategic investment in MediPro Direct, a nationwide provider of mobile diagnostics services. The partnership is intended to bring CGF’s operating experience to help expand MediPro Direct’s provider network, enhance its technology platform, and pursue additional partnerships across its healthcare and clinical trial markets.
New Harbor Capital’s portfolio company MD Esthetics completed four strategic add-on acquisitions in the first half of 2026. The acquisitions increased MD Esthetics from 12 to 35 total locations and marked entry into new Pennsylvania and Vermont markets, expanding its multi-site medical aesthetics and wellness platform across the Northeast.
MRO, a clinical data management platform, announced the acquisition of Vyne Medical, which provides data intake and intelligent document processing solutions for more than 800 hospitals nationwide. The deal expands MRO’s Enterprise Clinical Data Management platform across the clinical data lifecycle by adding capabilities to capture and digitize unstructured clinical information (e.g., paper, voice, fax, and images) and route it into structured data for downstream workflows.
Medallion acquired Andros, an NCQA-certified credentials verification organization. The deal adds Andros’ credentialing relationships and operations to Medallion’s AI-assisted credentialing and enrollment platform, enabling a unified system for credentialing, enrollment, licensing, and provider data management across nearly 400 healthcare organizations and health plans.
Hello Patient, an agentic AI company for patient communications, announced it acquired Converse Health, an AI workflow automation company for outpatient medical practices. The acquisition expands Hello Patient’s capabilities from front-office patient communication into back-office workflows such as referral/fax intake, chart-driven follow-up, authorization paperwork, and records/registration.
Spa Medicca announced a partnership with Dr. Nicholas E. Sherock LLC & Associates, a women's health practice serving the Massillon and Orrville, Ohio communities. The agreement brings the practice into the Spa Medicca family, providing operational support and resources while continuing to deliver the same patient care.
Veracyte announced its acquisition of Convergent Genomics to add the UroAmp urinary tumor DNA (utDNA) platform to its cancer diagnostics portfolio. The technology is intended to help guide non-muscle-invasive bladder cancer care by enabling urine-based therapy-response monitoring and post-treatment surveillance.
Addus HomeCare has signed a definitive agreement to acquire AccentCare’s personal care division covering operations outside New York for approximately $275.0 million, subject to customary adjustments and closing conditions. The acquired business serves an average daily census of about 13,700 customers across a 10-state footprint and is expected to add roughly $280 million in annualized personal care revenue.
Daia Orthodontics & TMJ Orthopedics announced its expansion into Canada by acquiring four orthodontic clinics across the Maritime provinces. The acquired clinics (formerly docbraces) will continue operating under their existing clinical and administrative teams while serving local communities in Grand Falls NB, Woodstock NB, Charlottetown PEI, and Summerside PEI.
Kyndryl completed its acquisition of Healthcare IT Leaders, LLC for up to $350 million, including an earnout. The combined capabilities span applications, infrastructure, and consulting services to help healthcare providers and payors modernize mission-critical technology environments.
Perdoceo Education Corporation has entered into a definitive agreement to acquire 100% of the membership interests of South University Savannah, LLC (South University) from South University – Member, Inc. The transaction is valued at approximately $130 million to $140 million paid at closing, plus $18 million of deferred consideration and up to $56 million in earn-out payments tied to EBITDA thresholds through fiscal 2029. Closing is expected as early as April 2027, subject to customary regulatory and accreditor approvals.
Endpoint Clinical L.P., a portfolio company of Arsenal Capital Partners, acquired Bluefin, a Boston-based provider of clinical supply forecasting and planning technology. The deal is designed to expand Endpoint into clinical supply planning while keeping Bluefin independent and RTSM-agnostic, operating its forecasting and planning mission.
Medtronic plc has announced an exchange offer that would allow MiniMed to become fully autonomous, with Medtronic shareholders exchanging Medtronic ordinary shares for MiniMed common stock. After the exchange offer (including related transactions) is effectuated, Medtronic expects it will no longer hold an equity stake in MiniMed.
Amulet Capital Partners closed a recapitalization of US Fertility through a new continuation vehicle to support the fertility services platform’s continued growth. StepStone acted as the sole lead investor, with other existing and new investors participating. Financial terms were not disclosed.
ABL Diagnostics (ABLD) announced it filed a takeover bid to acquire IntegraGen’s business operations and assets. The target is currently subject to judicial reorganization proceedings before the Commercial Court of Évry, and the bid remains subject to the court’s decision and selection as successful bidder.
Axogen has entered into a definitive agreement to acquire BioCircuit Technologies for $200 million in cash, adding NerveTape—an FDA-approved sutureless peripheral nerve repair device—to its portfolio. The company expects the transaction to close in the fourth quarter of 2026, subject to customary conditions and completion of the spinout of BioCircuit’s electronics research and development business.
Spire Healthcare Group has agreed to be acquired by a consortium of funds managed by Toscafund Asset Management, Three Hills and Ares in a deal valuing the UK private healthcare operator at about £1.026 billion. The consortium will pay 250 pence per Spire share, representing a 66% premium to the company’s market capitalization on May 13, and shareholders holding about 53.4% have agreed to support the offer.
LUX Infusion acquired two ambulatory infusion centers—South Jersey Pediatric and Adult Infusion Center in Cherry Hill, New Jersey and Northeast Infusion Therapy in Latham, New York. The acquisitions expand LUX Infusion’s ambulatory infusion center footprint and support its clinician-led model of patient-centered, physician-collaborative infusion care.
Full Export
Get the full acquisitions list for this page as CSV + XLSX.
Find buyers actively acquiring healthcare services companies.
Recent deals include healthcare supply chain and inventory intelligence (e.g., SxanPro), clinical data and document intake platforms (e.g., Vyne Medical), credentialing and enrollment tools (e.g., Andros), and provider network intelligence (e.g., Defacto Health).
Yes. The page includes an advanced therapies CDMO merger creating Kincellis Advanced Therapies, and a diagnostics-focused acquisition by Veracyte to add the UroAmp urinary tumor DNA platform via Convergent Genomics.
The most recent locations include the United States, Ontario (Canada), and the United Kingdom.
Both appear. For example, Kincell Bio and Cellipont Bioservices merged to form Kincellis Advanced Therapies, and Spire Healthcare Group is covered via a consortium-backed acquisition agreement in the United Kingdom.